Page 42 - Demo

ANALESRANFwww.analesranf.comoverexpressed in human fat cells from insulinresistant subjects. J Biol Chem, 2003. 278(46): p.45777-84, DOI: 10.1074/jbc.M301977200.97. Li, H., et al., Chronic olanzapine administration causesmetabolic syndrome through inflammatory cytokinesin rodent models of insulin resistance. Sci Rep, 2019.9(1):p. 1582, DOI: 10.1038/s41598-018-36930-y.98. Zhang, Q., et al., Effects of olanzapine on the elevationof macrophage infiltration and pro-inflammatorycytokine expression in female rats. JPsychopharmacol, 2014. 28(12): p. 1161-9, DOI:10.1177/0269881114555250.99. Davey, K.J., et al., Gender-dependent consequences ofchronic olanzapine in the rat: effects on body weight,inflammatory, metabolic and microbiota parameters.Psychopharmacology (Berl), 2012. 221(1): p. 155-69,DOI: 10.1007/s00213-011-2555-2.100. Shoelson, S.E., J. Lee, and A.B. Goldfine, Inflammationand insulin resistance. J Clin Invest, 2006. 116(7): p.1793-801, DOI: 10.1172/JCI29069.101. Cui, D., et al., Macrophage migration inhibitory factormediates metabolic dysfunction induced by atypicalantipsychotic therapy. J Clin Invest, 2018. 128(11): p.4997-5007, DOI: 10.1172/JCI93090.102. Coccurello, R., et al., Olanzapine (LY170053, 2-methyl4-(4-methyl-1-piperazinyl)- 10H-thieno(2,3-b)(1,5)benzodiazepine), but not the novel atypicalantipsychotic ST2472(9-piperazin-1-ylpyrrolo(2,1-b)(1,3)benzothiazepine), chronic administrationinduces weight gain, hyperphagia, and metabolicdysregulation in mice. J Pharmacol Exp Ther, 2008.326(3): p. 905-11, DOI: 10.1124/jpet.108.137240.103. Hou, P.H., et al., Long-term administration of olanzapineinduces adiposity and increases hepatic fatty aciddesaturation protein in female C57BL/6J mice. Iran JBasic Med Sci, 2018. 21(5): p. 495-501, DOI:10.22038/IJBMS.2018.22759.5780.104.Li, R., et al., The Wnt Signaling Pathway Effector TCF7L2Mediates Olanzapine- Induced Weight Gain and InsulinResistance. Front Pharmacol, 2018. 9: p. 379, DOI:10.3389/fphar.2018.00379.105. Albaugh, V.L., et al., Olanzapine promotes fataccumulation in male rats by decreasing physicalactivity, repartitioning energy and increasing adiposetissue lipogenesis while impairing lipolysis. MolPsychiatry, 2011. 16(5): p. 569-81, DOI:10.1038/mp.2010.33.106. Zhang, X., et al., Regulation of obesity-associatedmetabolic disturbance by the antipsychotic drugolanzapine: Role of the autophagy-lysosome pathway.Biochem Pharmacol, 2018. 158: p. 114-125, DOI:10.1016/j.bcp.2018.10.001.107. Kunnari, A.M., et al., The expression of human resistin indifferent leucocyte lineages is modulated by LPS andTNFalpha. Regul Pept, 2009. 157(1-3): p. 57-63, DOI:10.1016/j.regpep.2009.05.002.108. Schwartz, D.R. and M.A. Lazar, Human resistin: found intranslation from mouse to man. Trends EndocrinolMetab, 2011. 22(7): p. 259-65, DOI:10.1016/j.tem.2011.03.005.109. Klemettila, J.P., et al., Resistin as an inflammatorymarker in patients with schizophrenia treated withclozapine. Nord J Psychiatry, 2017. 71(2): p. 89-95,affect basal or insulin-stimulated glucose transport in3T3-L1 adipocytes. Prog Neuropsychopharmacol BiolPsychiatry, 2006. 30(1): p. 93-8, DOI:10.1016/j.pnpbp.2005.06.008.83. Albaugh, V.L., et al., Hormonal and metabolic effects ofolanzapine and clozapine related to body weight inrodents. Obesity (Silver Spring), 2006. 14(1): p. 36-51,DOI: 10.1038/oby.2006.6.84. Zugno, A.I., et al., Energy metabolism, leptin, andbiochemical parameters are altered in rats subjectedto the chronic administration of olanzapine. Braz JPsychiatry, 2012. 34(2): p. 168-75.85. Goudie, A.J., J.A. Smith, and J.C. Halford,Characterization of olanzapine-induced weight gain inrats. J Psychopharmacol, 2002. 16(4): p. 291-6, DOI:10.1177/026988110201600402.86. Volpato, A.M., A.I. Zugno, and J. Quevedo, Recentevidence and potential mechanisms underlying weightgain and insulin resistance due to atypicalantipsychotics. Braz J Psychiatry, 2013. 35(3): p. 295-304, DOI: 10.1590/1516-4446- 2012-1052.87. Yang, C.P., et al., Olanzapine Induced DysmetabolicChanges Involving Tissue Chromium Mobilization inFemale Rats. Int J Mol Sci, 2019. 20(3), DOI:10.3390/ijms20030640.88. Pouzet, B., et al., Chronic treatment with antipsychoticsin rats as a model for antipsychotic-induced weightgain in human. Pharmacol Biochem Behav, 2003. 75(1):p. 133-40.89. Horska, K., et al., Olanzapine-depot administrationinduces time-dependent changes in adipose tissueendocrine function in rats. Psychoneuroendocrinology,2016. 73: p. 177-185, DOI:10.1016/j.psyneuen.2016.07.218.90. Tan, W., H. Fan, and P.H. Yu, Induction of subcutaneousadipose proliferation by olanzapine in rodents. ProgNeuropsychopharmacol Biol Psychiatry, 2010. 34(6): p.1098-103, DOI: 10.1016/j.pnpbp.2010.06.002.91. Minet-Ringuet, J., et al., Alterations of lipid metabolismand gene expression in rat adipocytes during chronicolanzapine treatment. Mol Psychiatry, 2007. 12(6): p.562- 71, DOI: 10.1038/sj.mp.4001948.92. Duncan, G.E., S. Zorn, and J.A. Lieberman, Mechanismsof typical and atypical antipsychotic drug action inrelation to dopamine and NMDA receptor hypofunctionhypotheses of schizophrenia. Mol Psychiatry, 1999.4(5): p. 418-28.93. Lafontan, M., et al., Adrenergic receptors and fat cells:differential recruitment by physiological amines andhomologous regulation. Obes Res, 1995. 3 Suppl 4: p.507S-514S.94. Victoriano, M., et al., Olanzapine-induced accumulationof adipose tissue is associated with an inflammatorystate. Brain Res, 2010. 1350: p. 167-75, DOI:10.1016/j.brainres.2010.05.060.95. Calevro, A., et al., Effects of chronic antipsychotic drugexposure on the expression of Translocator Proteinand inflammatory markers in rat adipose tissue.Psychoneuroendocrinology, 2018. 95:p.28-33, DOI: 10.1016/j.psyneuen.2018.05.021.96. Rotter, V., I. Nagaev, and U. Smith, Interleukin-6 (IL-6)induces insulin resistance in 3T3-L1 adipocytes and is,like IL-8 and tumor necrosis factor-alpha,F%u00e1rmacos antipsic%u00f3ticos de segunda generaci%u00f3n y su impactoen el tejido adiposoPatricia Rada, V%u00edtor Ferreira y %u00c1ngela M. Valverde41 An. R. Acad. Farm.Vol. 90. n%u00ba 1 (2024) %u00b7 pp. 21-44